Novolog Mix 50/50 Purple Book BLA 021810

BLA number
021810
Proprietary names
Novolog Mix 50/50
Proper names
insulin aspart protamine and insulin aspart
Applicant
Novo Nordisk Inc.
Center
CDER
First observed release
2020-05-01
Latest observed release
2026-06-01
Newest archive release
2026-06-01
FDA patent list
No patents listed in the captured FDA patent list; source updated 2025-06-11
Coverage
Present in newest release

Latest Known Product Presentations#

Product, Proprietary name, Proper name table
ProductProprietary nameProper nameLicense typeStrengthDosage formRoutePresentationMarketingLicensureApprovalPatent list provided
001Novolog Mix 50/50insulin aspart protamine and insulin aspart351(a)150UNITS/3ML (50UNITS/ML); 150UNITS/3ML (50UNITS/ML)Injectable SuspensionSubcutaneousMulti-Dose CartridgeDiscVoluntarily Revoked2008-08-26
002Novolog Mix 50/50insulin aspart protamine and insulin aspart351(a)150UNITS/3ML (50UNITS/ML); 150UNITS/3ML (50UNITS/ML)Injectable SuspensionSubcutaneousAutoinjectorDiscVoluntarily Revoked2008-08-26

Published Patent List#

No patents for this BLA were listed in the FDA Purple Book patent list captured from the source updated 2025-06-11.

Official Monthly Change Events#

Release, Event, Product table
ReleaseEventProductNameLicense typeStatusApplicant
2022-08-01U001Novolog Mix 50/50351(a)DiscNovo Nordisk Inc.
2022-08-01U002Novolog Mix 50/50351(a)DiscNovo Nordisk Inc.
2021-08-01U002Novolog Mix 50/50351(a)DiscNovo Nordisk Inc.
2020-05-01R001Novolog Mix 50/50351(a)DiscNovo Nordisk Inc.
2020-05-01R002Novolog Mix 50/50351(a)DiscNovo Nordisk Inc.

Observed Product State History#

Release, Product, Name table
ReleaseProductNameLicense typeMarketingLicensureApproval
2022-08-01001Novolog Mix 50/50351(a)DiscVoluntarily Revoked2008-08-26
2022-08-01002Novolog Mix 50/50351(a)DiscVoluntarily Revoked2008-08-26
2020-05-01001Novolog Mix 50/50351(a)DiscLicensed2008-08-26
2020-05-01002Novolog Mix 50/50351(a)DiscLicensed2008-08-26